Miriam Koopman

Miriam Koopman

UNVERIFIED PROFILE

Are you Miriam Koopman?   Register this Author

Register author
Miriam Koopman

Miriam Koopman

Publications by authors named "Miriam Koopman"

Are you Miriam Koopman?   Register this Author

90Publications

1816Reads

39Profile Views

The era of alternative designs to connect randomized clinical trials and real-world data.

Nat Rev Clin Oncol 2019 Sep;16(9):589

Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-019-0250-0DOI Listing
September 2019

Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients.

Am J Clin Nutr 2019 Sep 12. Epub 2019 Sep 12.

Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcn/nqz209DOI Listing
September 2019

Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.

J Cachexia Sarcopenia Muscle 2019 Aug 15;10(4):803-813. Epub 2019 May 15.

Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcsm.12436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711417PMC
August 2019

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data.

Int J Cancer 2019 Aug 19. Epub 2019 Aug 19.

Department of Epidemiology and Biostatistics, Amsterdam UMC, VU University, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32629DOI Listing
August 2019

Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancer.

Patient Educ Couns 2019 07 22;102(7):1331-1335. Epub 2019 Feb 22.

Department of Medical Oncology, Amsterdam University Medical Centers, Location AMC, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2019.02.020DOI Listing
July 2019

Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer.

JNCI Cancer Spectr 2019 Jun 25;3(2):pkz014. Epub 2019 Apr 25.

Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pkz016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649832PMC
June 2019

Angiogenesis in Y-Radioembolization of Colorectal Liver Metastases.

Semin Nucl Med 2019 May 31;49(3):204-210. Epub 2019 Jan 31.

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2019.01.004DOI Listing
May 2019

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

BMC Cancer 2019 04 25;19(1):390. Epub 2019 Apr 25.

Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5545-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485075PMC
April 2019

Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancer.

Acta Oncol 2019 Mar 18;58(3):326-333. Epub 2019 Jan 18.

h Department of Medical Oncology , University Medical Center Utrecht, Utrecht University , Utrecht , The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2018.1564840DOI Listing
March 2019

A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy.

Eur J Cancer 2019 Jan 11;107:60-67. Epub 2018 Dec 11.

Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183147
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.11.010DOI Listing
January 2019

Comparing Strategies for Modeling Competing Risks in Discrete-Event Simulations: A Simulation Study and Illustration in Colorectal Cancer.

Med Decis Making 2019 01;39(1):57-73

Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0272989X18814770DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311678PMC
January 2019

Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients.

Cancer Epidemiol 2018 12 11;57:60-67. Epub 2018 Oct 11.

Health Technology and Services Research Department, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Centre, Utrecht University, Huispost STR 6.131, P.O. Box 85500, 3508 GA Utrecht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2018.09.008DOI Listing
December 2018

Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.

BMC Med Inform Decis Mak 2018 12 14;18(1):132. Epub 2018 Dec 14.

Department of Epidemiology and Biostatistics, Amsterdam UMC, location VUMC, F-wing Medical Faculty building, PO Box 7057 1007, MB, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12911-018-0712-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295030PMC
December 2018

Monitoring potentially modifiable lifestyle factors in cancer survivors: A narrative review on currently available methodologies and innovations for large-scale surveillance.

Eur J Cancer 2018 11 13;103:327-340. Epub 2018 Jul 13.

Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.06.017DOI Listing
November 2018

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.

Lancet Oncol 2018 11 19;19(11):1459-1467. Epub 2018 Oct 19.

Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045183068
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(18)30686-7DOI Listing
November 2018

Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients.

J Cachexia Sarcopenia Muscle 2018 10 24;9(5):909-919. Epub 2018 Aug 24.

Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcsm.12337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204584PMC
October 2018

Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab.

J Clin Oncol 2018 07 24;36(20):2052-2060. Epub 2018 May 24.

Erik van Dijk, Hedde D. Biesma, Martijn Cordes, Maarten Neerincx, Paul P. Eijk, Henk M.W. Verheul, Nicole C.T. van Grieken, and Bauke Ylstra, Vrije Universiteit Medical Center; Gerrit A. Meijer, Netherlands Cancer Institute; Cornelis J.A. Punt, Academic Medical Center, Amsterdam; Miriam Koopman, University Medical Center Utrecht, Utrecht, the Netherlands; Dominiek Smeets and Diether Lambrechts, KU Leuven, Leuven, Belgium; Sudipto Das, Orna Bacon, Jochen H.M. Prehn, Bryan T. Hennessey, Darran P. O'Connor, and Annette T. Byrne, Royal College of Surgeons in Ireland; Verena Murphy, Cancer Trials Ireland; Anna Barat, Deborah A. McNamara, and Elaine W. Kay, Beaumont Hospital; Bozena Fender and William M. Gallagher, OncoMark Ltd; Rut Klinger and William M. Gallagher, University College Dublin, Dublin, United Kingdom; Johannes Betge, Timo Gaiser, and Matthias P.A. Ebert, University Hospital Mannheim, Mannheim, Germany; and Fotios Loupakis, Veneto Institute of Oncology IOV-IRCCS Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.1782DOI Listing
July 2018

The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases.

Eur J Clin Pharmacol 2018 Jun 11;74(6):737-744. Epub 2018 Feb 11.

Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-018-2426-4DOI Listing
June 2018

Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review.

Eur J Cancer 2018 06 2;96:115-124. Epub 2018 May 2.

Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.03.026DOI Listing
June 2018

Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer.

Clin Pharmacokinet 2018 04;57(4):455-473

Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-017-0590-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856878PMC
April 2018

Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group.

Clin Colorectal Cancer 2018 03 20;17(1):58-64. Epub 2017 Nov 20.

Cancer Center Amsterdam, Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15330028173002
Publisher Site
http://dx.doi.org/10.1016/j.clcc.2017.10.007DOI Listing
March 2018

Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models.

BMC Med Res Methodol 2017 Dec 15;17(1):170. Epub 2017 Dec 15.

Health Technology and Services Research Department, MIRA institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12874-017-0437-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732462PMC
December 2017

Evaluating the scientific basis of quality indicators in colorectal cancer care: A systematic review.

Eur J Cancer 2017 11 6;86:166-177. Epub 2017 Oct 6.

Department of Medical Oncology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.08.034DOI Listing
November 2017

Case series of patients treated with the oral fluoropyrimidine S-1 after capecitabine-induced coronary artery vasospasm.

Eur J Cancer 2017 08 15;81:130-134. Epub 2017 Jun 15.

Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Mijbergdreef 9, 1105 AZ, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.05.022DOI Listing
August 2017

Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group.

Eur J Cancer 2017 05 10;76:93-99. Epub 2017 Mar 10.

Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Mijbergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.02.009DOI Listing
May 2017

From tumour heterogeneity to advances in precision treatment of colorectal cancer.

Nat Rev Clin Oncol 2017 04 6;14(4):235-246. Epub 2016 Dec 6.

Laboratory for Experimental Oncology and Radiobiology (LEXOR), Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105AZ Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://www.gastricbreastcancer.com/pdf/7.nrclinonc%202016%20
Web Search
http://dx.doi.org/10.1038/nrclinonc.2016.171DOI Listing
April 2017

Prognostic Relevance of Palliative Primary Tumor Removal: Why Randomized Controlled Data Are Still Mandatory.

Ann Surg 2017 04;265(4):e58-e59

Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001279DOI Listing
April 2017

Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry.

Clin Cancer Res 2017 Jan 26;23(2):387-398. Epub 2016 Jul 26.

Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0680DOI Listing
January 2017

Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.

Eur J Cancer 2016 12 5;69:166-177. Epub 2016 Nov 5.

Department of Medical Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.09.028DOI Listing
December 2016

Effects of an Exercise Program in Colon Cancer Patients undergoing Chemotherapy.

Med Sci Sports Exerc 2016 May;48(5):767-75

1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, THE NETHERLANDS; 2Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, THE NETHERLANDS; 3Unit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, SPAIN; 4Department of Clinical Sciences, University of Barcelona, Barcelona, SPAIN; 5Department of Rehabilitation, Nursing Science and Sport, University Medical Center Utrecht, Utrecht, THE NETHERLANDS; 6Department of Medical Oncology, St. Antonius Hospital, Nieuwegein, THE NETHERLANDS; 7Department of Internal Medicine-Medical Oncology, Orbis Medical Center, Sittard-Geleen, THE NETHERLANDS; 8Department of Internal Medicine, Meander Medical Center, Amersfoort, THE NETHERLANDS; 9Department of Medical Oncology, University Medical Center Utrecht, Utrecht, THE NETHERLANDS; 10Department of Surgery, Rivierenland Hospital, Tiel, THE NETHERLANDS; 11Department of Internal Medicine, Hofpoort Hospital, Woerden, THE NETHERLANDS; 12Department of Internal Medicine, Diakonessenhuis, Utrecht, THE NETHERLANDS; and 13Cancer Center, University Medical Center Utrecht, Utrecht, THE NETHERLANDS.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00005768-201605000-000
Publisher Site
http://dx.doi.org/10.1249/MSS.0000000000000855DOI Listing
May 2016

Cetuximab as First-line Treatment for Metastatic Colorectal Cancer: Caution With Interpretation of Cost-Effectiveness Results Toward Medical Decision Making.

Am J Clin Oncol 2016 Apr;39(2):214

*Department of Medical Oncology, University Medical Center Utrecht, Utrecht †Department of Medical Oncology, Academic Medical Center, University of Amsterdam Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000253DOI Listing
April 2016

Systemic treatment: maintenance compared with holiday.

Am Soc Clin Oncol Educ Book 2015 :85-90

From the Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.85DOI Listing
February 2016

Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data.

Lancet Oncol 2015 Dec 23;16(16):1639-50. Epub 2015 Oct 23.

Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S147020451500286
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(15)00286-7DOI Listing
December 2015

Maintenance treatment in metastatic colorectal cancer.

Lancet Oncol 2015 Dec;16(16):e582-3

Department of Medical Oncology, University Medical Center Utrecht, Utrecht 3584CX, Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00374-5DOI Listing
December 2015

Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases.

Clin Exp Metastasis 2015 Jun 22;32(5):457-65. Epub 2015 Apr 22.

Netherlands Comprehensive Cancer Organisation (IKNL), P.O. Box 19079, 3501 DB, Utrecht, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-015-9719-0DOI Listing
June 2015

Re: Generalizability of trial results to elderly medicare patients with advanced solid tumors.

J Natl Cancer Inst 2015 Jun 7;107(6):djv104. Epub 2015 May 7.

Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (CJAP); Department of Medical Oncology, University Medical Center, Utrecht, The Netherlands (MK); Department of Medical oncology, Radboud University Medical Center, Nijmegen, The Netherlands (PBO); Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen, The Netherlands (LM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv104DOI Listing
June 2015

Optimal duration of systemic treatment in metastatic colorectal cancer.

Curr Opin Oncol 2014 Jul;26(4):448-53

aDepartment of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam bDepartment of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000087DOI Listing
July 2014

Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin.

Mutat Res 2014 Jan 9;759:37-44. Epub 2013 Nov 9.

Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00275107130017
Publisher Site
http://dx.doi.org/10.1016/j.mrfmmm.2013.11.001DOI Listing
January 2014

Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samples.

Pharmacogenomics 2013 Dec;14(16):2005-12

Department of Clinical Oncology (K-1-P), Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.13.169DOI Listing
December 2013

Radioembolization for treatment of salvage patients with colorectal cancer liver metastases: a systematic review.

J Nucl Med 2013 Nov 26;54(11):1890-5. Epub 2013 Sep 26.

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.113.119545DOI Listing
November 2013

Real-world cost-effectiveness of oxaliplatin in stage III colon cancer: a synthesis of clinical trial and daily practice evidence.

Pharmacoeconomics 2013 Aug;31(8):703-18

Department of Health Policy and Management, Institute for Medical Technology Assessment, Erasmus University, Burgemeester Oudlaan 50, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-013-0061-6DOI Listing
August 2013

Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands.

Acta Oncol 2013 Jun 21;52(5):950-5. Epub 2013 Mar 21.

Clinical trial centre, Comprehensive Cancer Centre The Netherlands, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2013.777158DOI Listing
June 2013

Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer.

Gut 2013 Jan 20;62(1):94-101. Epub 2012 Jan 20.

Department of Pathology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://gut.bmj.com/lookup/doi/10.1136/gutjnl-2011-301587
Publisher Site
http://dx.doi.org/10.1136/gutjnl-2011-301587DOI Listing
January 2013

Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The Netherlands.

Eur J Cancer 2013 Jan 16;49(1):8-16. Epub 2012 Jul 16.

Institute for Medical Technology Assessment, Department of Health Policy and Management, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980491200501
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2012.06.010DOI Listing
January 2013

Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.

Eur J Cancer 2012 Mar 4;48(4):501-9. Epub 2012 Jan 4.

Department of Pathology, Radboud University Nijmegen Medical Centre, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2011.12.004DOI Listing
March 2012

Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.

Acta Oncol 2012 Jan 28;51(1):57-64. Epub 2011 Nov 28.

Institute for Medical Technology Assessment, Department of Health Policy and Management, Erasmus University Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2011.633930DOI Listing
January 2012

Surgery of the primary in stage IV colorectal cancer with unresectable metastases.

Eur J Cancer 2011 Sep;47 Suppl 3:S61-6

Daniel den Hoed Cancer Center, Department of Surgical Oncology, Erasmus MC, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0959-8049(11)70148-4DOI Listing
September 2011

Bevacizumab and cancer treatment-related mortality.

JAMA 2011 Jun;305(22):2292; author reply 2292-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2011.758DOI Listing
June 2011

Chemotherapy, which drugs and when.

Eur J Cancer 2009 Sep;45 Suppl 1:50-6

Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980490970016
Publisher Site
http://dx.doi.org/10.1016/S0959-8049(09)70016-4DOI Listing
September 2009

Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study.

Eur J Cancer 2009 Jul 18;45(11):1999-2006. Epub 2009 May 18.

Department of Medical Oncology, Radboud University Nijmegen Medical Center, 6500HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2009.04.017DOI Listing
July 2009

A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?

Eur J Cancer 2009 Jul 25;45(11):1935-49. Epub 2009 May 25.

Department of Medical Oncology, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2009.04.023DOI Listing
July 2009

The CAIRO and FOCUS studies: which lesson is to be learned?

Oncologist 2009 Feb;14(2):192-3; author reply 194-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2008-0247DOI Listing
February 2009

Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case.

Dis Colon Rectum 2008 Sep 10;51(9):1425-6. Epub 2008 May 10.

Department of Medical Oncology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10350-008-9282-8DOI Listing
September 2008

Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group.

Clin Colorectal Cancer 2008 Mar;7(2):105-9

Department of Medical Oncology, Radboud University Nijmegen Medical Center, The Netherlands.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S153300281170406
Publisher Site
http://dx.doi.org/10.3816/CCC.2008.n.014DOI Listing
March 2008

A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer.

Expert Opin Pharmacother 2007 Jun;8(9):1313-28

Institute for Medical Technology Assessment, Erasmus Medical Centre, PO Box 1738, 3000 DR Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.8.9.1313DOI Listing
June 2007